Differences in Clot Preparation Determine Outcome of Recombinant Tissue Plasminogen Activator Treatment in Experimental Thromboembolic Stroke
- 1 August 2003
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (8) , 2019-2024
- https://doi.org/10.1161/01.str.0000080941.73934.30
Abstract
Thrombin-induced clots used in experimental thromboembolic stroke differ from clots forming spontaneously under clinical conditions. We investigated whether this difference influences the efficacy and outcome of thrombolytic treatment. In rats, the middle cerebral artery was occluded by intracarotid injection of fibrin-rich clots, prepared either according to established methods by adding thrombin to freshly drawn arterial blood or by spontaneous coagulation. The mechanical properties of clots were determined in vitro by elasticity and plasticity tests. One hour after embolism, thrombolysis was started by intra-arterial application of recombinant tissue plasminogen activator (rtPA) (10 mg/kg). Treatment efficacy was monitored by MR measurements of blood perfusion, apparent diffusion coefficient (ADC), T2 relaxation time and blood-brain barrier permeability, and by pictorial measurements of ATP and pH. Thrombin-induced clots were classified as elastic, and spontaneously forming clots were classified as plastic. Middle cerebral artery embolism with thrombin-induced or spontaneously forming clots led to similar reduction of perfusion and ADC, but rtPA treatment efficacy differed greatly. In the spontaneously forming clot group, blood perfusion returned to or above control within 2 hours, ADC and ATP normalized, tissue pH exhibited alkalosis, and T2 and blood-brain barrier permeability did not change. In the thrombin-induced clot group, in contrast, blood reperfusion was delayed, ADC and ATP remained reduced, tissue pH was acidic, and edema developed, as reflected by increased T2 and blood-brain barrier permeability. rtPA-induced thrombolysis promotes rapid reperfusion and tissue recovery in animals embolized with spontaneously forming clots but not in those embolized with thrombin-induced clots. This difference is explained by the different mechanical and possibly molecular consequences of clot preparation and must be considered for the interpretation of thrombolysis experiments.Keywords
This publication has 18 references indexed in Scilit:
- Thrombolytic Treatment of Clot Embolism in RatStroke, 2002
- Magnetic Resonance Angiography of Thromboembolic Stroke in Rats: Indicator of Recanalization Probability and Tissue Survival after Recombinant Tissue Plasminogen Activator TreatmentJournal of Cerebral Blood Flow & Metabolism, 2002
- Prediction of Hemorrhagic Transformation After Thrombolytic Therapy of Clot EmbolismStroke, 2002
- Thrombin Hydrolysis of V29F and V34L Mutants of Factor XIII (28−41) Reveals Roles of the P9 and P4 Positions in Factor XIII ActivationBiochemistry, 2002
- Variability in plasma prothrombin concentrationBlood Coagulation & Fibrinolysis, 1998
- The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous systemBrain Research Reviews, 1997
- REPERFUSION OF THE BRAIN AFTER GLOBAL ISCHEMIAShock, 1997
- Intracerebral infusion of thrombin as a cause of brain edemaJournal of Neurosurgery, 1995
- The thrombin paradoxNature, 1995
- Evolution of Regional Changes in Apparent Diffusion Coefficient during Focal Ischemia of Rat Brain: The Relationship of Quantitative Diffusion NMR Imaging to Reduction in Cerebral Blood Flow and Metabolic DisturbancesJournal of Cerebral Blood Flow & Metabolism, 1995